LEMAITRE VASCULAR INC LMAT Income Statement

Lemaitre vascular inc (LMAT)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net Sales
30,551	30,170	29,100	29,483	28,479	28,389	24,165	27,020	25,994	26,153	24,822	25,753	24,139	23,288	23,216	22,389	20,258	20,483	19,025	19,897	18,947	18,681	17,501	18,161	16,754	17,916	15,300	15,951	15,382	14,801	13,645	14,361	13,928	13,411	14,564	15,112	14,598	13,656	14,158
Cost of sales
10,068	10,262	8,934	9,168	9,015	9,171	6,910	8,028	7,520	7,901	7,245	8,238	6,786	7,094	6,197	7,022	5,902	6,080	5,509	6,767	5,830	5,853	5,498	5,785	5,530	5,960	4,584	4,714	4,176	4,363	3,630	3,816	4,058	3,888	4,381	4,742	4,447	3,258	3,502
Gross profit
20,483	19,908	20,166	20,315	19,464	19,218	17,255	18,992	18,474	18,252	17,577	17,515	17,353	16,194	17,019	15,367	14,356	14,403	13,516	13,130	13,117	12,828	12,003	12,376	11,224	11,956	10,716	11,237	11,206	10,438	10,015	10,545	9,870	9,523	10,183	10,370	10,151	10,398	10,656
Sales and marketing
7,945	7,452	7,429	7,613	7,845	6,814	6,622	6,792	7,090	6,194	6,201	6,599	6,954	6,752	6,541	6,539	6,273	5,914	5,489	5,519	5,858	5,230	5,091	5,537	6,229	5,865	5,205	5,305	5,768	5,501	4,911	5,186	5,213	4,729	4,757	4,916	4,973	4,698	4,747
General and administrative
5,191	5,029	4,551	4,531	4,944	4,462	3,983	4,547	4,697	4,153	4,562	3,747	4,548	4,011	3,595	3,411	3,337	3,635	3,455	3,303	3,617	3,513	3,765	3,296	3,315	3,345	3,282	3,067	2,882	2,696	2,892	2,717	2,668	2,711	2,802	2,867	2,848	2,533	2,495
Research and development
2,994	2,499	2,281	2,256	2,240	2,347	2,037	1,988	1,825	1,583	1,761	1,634	1,658	1,522	1,539	1,634	1,446	1,575	1,421	1,331	1,152	1,081	1,109	1,137	1,344	1,402	1,300	1,268	1,273	1,561	1,261	1,135	1,135	1,139	974	1,040	1,272	1,135	1,338
Gain on acquisitions and divestitures
-	-	-	-	-	-	-	5,876	-	-	-	-	-	-	-	-	-	-	360	-	-	-	-	-	-	-	-	-	-	-	50	52	-	-	-735	-	-	-	-
Medical device excise tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	190	190	183	181	171	178	176	164	172	153	150	160	-	-	0	-	-	-	-	-	-	-
Restructuring charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26	8	89	403	-	-	-	-	-	-	-	-	112	394	650	1,005	-	-
Impairment charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	161	-	-	-	-	-	-	-	-	-	0	0	0	83	-	68
Total operating expenses
16,130	14,980	14,261	14,400	15,029	12,025	12,642	7,451	13,612	11,930	12,524	11,980	13,160	12,285	11,675	11,584	11,056	11,314	10,195	10,336	10,808	10,089	10,151	10,396	11,455	10,784	9,940	9,790	10,083	9,508	9,014	9,090	9,016	8,691	8,192	9,473	10,181	8,366	8,648
Income from operations
4,353	4,928	5,905	5,915	4,435	7,193	4,613	11,541	4,862	6,322	5,053	5,535	4,193	3,909	5,344	3,783	3,300	3,089	3,321	2,794	2,309	2,739	1,852	1,980	-231	1,172	776	1,447	1,123	930	1,001	1,455	854	832	1,991	897	-30	2,032	2,008
Other income (expense):
Interest income
105	124	193	224	157	179	192	165	95	79	48	32	20	26	24	16	15	-	3	4	-	-	1	-	-	0	1	2	1	10	47	14	7	4	4	2	1	8	9
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	6	-	-	-6	6	8	4	-	-	0	-	-	-	-	-	-	-
Foreign currency gain (loss)
-178	136	-208	-51	-79	-119	-75	-159	-41	-51	-28	-102	26	-87	-61	37	-50	40	-185	26	17	-46	52	20	-42	-80	14	-66	-50	-84	7	-49	-198	-44	-49	5	139	35	-68
Income before income taxes
4,280	5,188	5,890	6,088	4,513	7,251	4,730	11,547	4,916	6,329	5,073	5,465	4,239	3,834	5,307	3,836	3,265	3,135	3,139	2,824	2,326	2,694	1,899	2,000	-273	1,098	785	1,375	1,070	855	1,055	1,420	663	784	1,946	904	118	2,065	1,963
Other income, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	8	-10	14
Provision for income taxes
1,106	575	706	1,464	1,000	1,226	416	2,796	1,063	2,045	31	833	1,020	1,237	2,078	1,238	1,099	605	1,047	1,057	957	778	965	728	-66	352	64	486	224	157	392	596	277	438	732	385	54	548	452
Net income
3,174	4,613	5,184	4,624	3,513	6,025	4,314	8,751	3,853	4,284	5,042	4,632	3,219	2,597	3,229	2,598	2,166	2,530	2,092	1,767	1,369	1,916	934	1,272	-207	746	721	889	846	698	663	824	386	346	1,214	519	64	1,517	1,511
Earnings per share of common stock:
Basic (in dollars per share)
0.16	0.24	0.26	0.23	0.18	0.31	0.22	0.45	0.20	0.23	0.26	0.25	0.17	0.14	0.17	0.14	0.12	0.14	0.12	0.10	0.08	0.12	0.05	0.08	-0.01	0.04	0.05	0.06	0.06	0.05	0.04	0.05	0.03	-	0.08	0.03	-	0.10	0.10
Diluted (in dollars per share)
0.16	0.23	0.25	0.23	0.17	0.30	0.21	0.43	0.19	0.22	0.25	0.23	0.16	0.13	0.17	0.14	0.11	0.13	0.11	0.10	0.08	0.11	0.05	0.08	-0.01	0.04	0.05	0.06	0.05	0.05	0.04	0.05	0.02	-	0.08	0.03	-	0.09	0.09
Weighted-average shares outstanding:
Basic (in shares)
20,168	20,061	19,871	19,680	19,640	19,598	19,503	19,320	19,283	19,273	19,124	18,816	18,631	18,672	18,524	18,408	18,336	18,187	17,865	17,582	17,422	17,409	17,348	16,113	15,586	15,460	15,339	15,250	15,219	15,151	15,130	15,201	15,294	15,406	15,491	15,470	15,465	15,622	15,613
Diluted (in shares)
20,438	20,475	20,378	20,246	20,205	20,234	20,293	20,260	20,181	20,303	20,147	19,975	19,707	19,878	19,248	18,978	18,860	18,906	18,497	18,065	17,796	18,192	17,709	16,545	15,586	15,927	15,780	15,701	15,648	15,585	15,605	15,636	15,726	15,817	16,030	16,071	16,038	16,157	16,050
Cash dividends declared per common share (in dollars per share)
0.09	0.08	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	-	-